medigraphic.com
ISSN 1560-4381 (Impreso)

2020, Número 4

<< Anterior Siguiente >>

Correo Científico Médico 2020; 24 (4)


Trombosis venosa profunda de miembros superiores

Yánez NAE, Yumiceba DGF, Zurita NJT, Torres AVV, Acosta YGC

Idioma: Español
Referencias bibliográficas: 31
Paginas: 1226-1244
Archivo PDF: 271.65 Kb.


RESUMEN

La trombosis venosa profunda (TVP) de la extremidad superior es una forma inusual de enfermedad tromboembólica venosa que afecta principalmente las venas braquiales, axilares y subclavias. Sus manifestaciones clínicas incluyen dolor, edema y cianosis de los miembros superiores, cuyo diagnóstico requiere la utilización de la imagenología, principalmente el ultrasonido y la venografía de contraste. Su tratamiento farmacológico, un desafío médico, se basa en el uso de anticoagulantes, como heparina no fraccionada, heparina de bajo peso molecular, fondaparinux y anticoagulantes orales directos. La terapia trombolítica y el tratamiento intervencionista se utilizan en casos seleccionados. Esta revisión se realizó principalmente en PubMed Central, de US National Library of Medicine, National Institutes of Health (https://www.ncbi.nlm.nih.gov/pmc), en ClinicalKey (https://www.clinicalkey.com) y en SciELO (https://search.scielo.org).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Yashwantrao Karand Y, Hedgire S, Sanchez Y, Baliyan V, Mishra V, Ganguli S, Prabhakar A. Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther. 2016[citado 13 /09/2019];6(6):493-507. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220209/pdf/cdt-06-06-493.pdf

  2. Attaran R. Latest Innovations in the Treatment of Venous Disease. J Clin Med. 2018[citado 13 /09/2019];7(4):77. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920451/pdf/jcm-07-00077.pdf

  3. Lazo Langner A. Studies in upper extremity deep vein thrombosis: Addressing the knowledge gaps. Res Pract Thromb Haemost.2019[citado 13/09/2019];3(3):312–314. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611369/pdf/RTH2-3-312.pdf

  4. Hughes E. Venous obstruction in the upper extremity. Br J Surg. 1948[citado 13/09/2019]; 36(142):155-163. Disponible en: https://bjssjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/bjs.18003614206

  5. Cires Drouet R, Sharma J, McDonald T, Sorkin J, Lal B. Variability in the management of line-related upper extremity deep vein thrombosis. Phlebology. 2019[citado 13/10/2019]; 34(8): 552–558. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012441/pdf/nihms-1068019.pdf

  6. Buitrago LE, Casas CP, Solano MH. Trombosis inusuales y trombofilia. Un problema difícil de abordar. Experiencia de cuatro años. Acta Méd Colombiana. 2013[citado 13/09/2019];38(3): 132-137. Disponible en: https://www.redalyc.org/pdf/1631/163128381008.pdf

  7. Mosevoll K, Johansen S, Wendelbo Ø, Nepstad I, Bruserud Ø, Reikvam H. Cytokines, Adhesion Molecules, and Matrix Metalloproteases as Predisposing, Diagnostic, and Prognostic Factors in Venous Thrombosis. Front Med. 2018[citado 13/09/2019];5:147.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972295/pdf/fmed-05-00147.pdf

  8. Sadeghi R, Safi M. Systemic thrombolysis in the upper extremity deep vein thrombosis. ARYA Atherosclerosis 2011[citado 13/09/2019]; 7(1): 40-46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347843/pdf/ARYA-7-040.pdf

  9. Nikolova Vlahova MK, Nikolov K, Baleva M, Savov A. Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis. Cent Eur J Immunol. 2015[citado 13/09/2019];40(3): 307-310. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655380/pdf/CEJI-40-25873.pdf

  10. Carlon T, Sudheendra D. Interventional Therapy for Upper Extremity Deep Vein Thrombosis. Semin Intervent Radiol. 2017[citado 13/10/2019]; 34(1): 54–60. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334483/pdf/10-1055-s-0036-1597764.pdf

  11. Vila Betancor JA, Solís Pérez Q, Medina Batista J. Actualización diagnóstico-terapéutica del síndrome antifosfolípido o de Hughes. CCM. 2018[citado 13/09/2019];22(3).Disponible en: http://revcocmed.sld.cu/index.php/cocmed/article/view/2788

  12. Mansour A, Saadeh S, Abdel Razeq N, Khozouz O, Abunasser M, Taqash A. Clinical Course and Complications of Catheter and Non-Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with Cancer. Clin Appl Thromb Hemost. 2018[citado 13/09/2019]; 24(8):1234–1240. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714774/pdf/10.1177_1076029618788177.pdf

  13. Tippit D, Siegel E, Ochoa D, Pennisi A, Hill E, Merrill A, et al. Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters. Breast Cancer (Auckl).2018[citado 13/09/2019];12:1-10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987887/pdf/10.1177_1178223418771909.pdf

  14. Zhang X, Huang JJ, Xia Y, Li CF, Wang Y, Liu PP, et al. High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma. Oncotarget. 2016[citado 13 /05/2019]; 7(23): 35404–35411. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085238/pdf/oncotarget-07-35404.pdf

  15. Lv Y, Hou Y, Pan B, Ma Y, Li P, Yu L, et al. Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis. Oncotarget. 2018[citado 13/05/2019]; 9(15): 12376–12388. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844754/pdf/oncotarget-09-12376.pdf

  16. Ouriel K. Central Venous Pathologies: Treatments and Economic Impact. Methodist Debakey Cardiovasc J. 2018[citado 13/05/2019];14(3):166-172. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217555/

  17. Heil J, Miesbach W, Vogl T, Bechstein WO, Reinisch A. Deep Vein Thrombosis of the Upper Extremity. A Systematic Review. Dtsch Arztebl Int. 2017[citado 13/09/2019];114(14):244–249. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415909/pdf/Dtsch_Arztebl_Int-114-0244.pdf

  18. Shenthar J, Padmanabhan D, Banavalikar B, Parvez J, Vallapil SP, Singha I, et al. Incidence, predictors, and gradation of upper extremity venous obstruction after transvenous pacemaker implantation. Indian Heart J. 2019[citado 13/09/2019];71(2):123-125. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620414/

  19. Ploton G, Pistorius MA, Raimbeau A, Le Seve JD, Bergère G, Ngohou C, et al. A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis. Medicine (Baltimore). 2020[citado 13 /09/2019]; 99(6): 18996. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015650/

  20. Rosen T, Chang B, Kaufman M, Soderman M, Riley DC. Emergency department diagnosis of upper extremity deep venous thrombosis using bedside ultrasonography. Crit Ultrasound J.2012 [citado 10/05/2019];4(1):4. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397657/

  21. Friedman T, Quencer KB, Kishore SA, Winokur RS, Madoff DC. Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond. Semin Intervent Radiol.2017 [citado 25/05/2019];34(4):398–408. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730434/pdf/10-1055-s-0037-1608863.pdf

  22. Delluc A, Le Mao R, Tromeur C, Chambry N, Rault Nagel H, Bressollette L, et al. Incidence of upper-extremity deep vein thrombosis in western France: a community-based study. Haematologica. 2018[citado 20/05/2019];104(1):29-31. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312028/

  23. Lim W, Le Gal G, Bates SM, Righini M, Haramati LB, Lang E, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv. 2018[citado26/10/2019];2(22): 3226-3256. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258916/pdf/advances024828CG.pdf

  24. Woller SC, Stevens SM, Johnson SA, Bledsoe JR, Galovic B, Lloyd JF, et al. Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM‐DVT): Methods of a prospective single‐arm management study. Res Pract Thromb Haemost. 2019[citado28/10/2019]; 3(3): 340–348. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611360/pdf/RTH2-3-340.pdf

  25. Streiff MB, Agnelli G, Connors JM, Crowther M, Eichinger S, Lopes R, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis. 2016[citado 13 sept 2019];41: 32–67. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715858/pdf/11239_2015_Article_1317.pdf

  26. Lv S, Liu Y, Wei G, Shi X, Chen S, Zhang X. The anticoagulants rivaroxaban and low molecular weight heparin prevent PICC-related upper extremity venous thrombosis in cancer patients. Medicine (Baltimore).2019[citado 14/11/2019]; 98(47):17894. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882624/

  27. Sánchez Montiel F, Ghazvinian R, Gottsäter A, Elf J. Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis. Thromb J. 2017[citado25/04/2019];15:26. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625705/pdf/12959_2017_Article_149.pdf

  28. Feinberg J, Nielsen EE, Jakobsen JC. Thrombolysis for acute upper extremity deep vein thrombosis. Cochrane Database Syst Rev. 2017[citado 24/03/2019]; 2017(12):12175. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486280/pdf/CD012175.pdf

  29. Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev.2016[citado 30/06/2020];2016(11):2783. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464997/pdf/CD002783.pdf

  30. Brækkan SK, Caram Deelder C, Siegerink B, van Hylckama Vlieg A, le Cessie S, Rosendaal FR, et al. Statin use and risk of recurrent venous thrombosis: results from the MEGA follow-up study. Res Pract Thromb Haemost. 2017[citado 02/10/2019];1(1):112–119. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12003

  31. Sista AK, Vedantham S, Kaufman JA, Madoff DC. Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art. Radiology. 2015[citado 12/02/2020]; 276 (1): 31-53. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4787709/pdf/radiol.2015132603.pdf




2020     |     www.medigraphic.com